168 related articles for article (PubMed ID: 24292975)
1. Pathologic reporting of lymph node metastases in differentiated thyroid cancer: a call to action for the College of American Pathologists.
Urken ML; Mechanick JI; Sarlin J; Scherl S; Wenig BM
Endocr Pathol; 2014 Sep; 25(3):214-8. PubMed ID: 24292975
[TBL] [Abstract][Full Text] [Related]
2. A response to the "call to action" on pathologic reporting of lymph node metastases in differentiated thyroid cancer from the college of american pathologists.
Seethala RR; Baker TP; Simpson JF
Endocr Pathol; 2014 Dec; 25(4):441-2. PubMed ID: 25038726
[No Abstract] [Full Text] [Related]
3. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension.
Randolph GW; Duh QY; Heller KS; LiVolsi VA; Mandel SJ; Steward DL; Tufano RP; Tuttle RM;
Thyroid; 2012 Nov; 22(11):1144-52. PubMed ID: 23083442
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Metastatic Lymph Nodes on Risk Stratification in Differentiated Thyroid Cancer: Have We Reached a Higher Level of Understanding?
Urken ML; Haser GC; Likhterov I; Wenig BM
Thyroid; 2016 Apr; 26(4):481-8. PubMed ID: 26892765
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
Wu MH; Shen WT; Gosnell J; Duh QY
Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
[TBL] [Abstract][Full Text] [Related]
6. [The significance of lymph node status in papillary and follicular thyroid gland carcinoma for the nuclear medicine physician].
Farahati J; Mörtl M; Reiners C
Zentralbl Chir; 2000; 125(10):830-4. PubMed ID: 11098578
[TBL] [Abstract][Full Text] [Related]
7. Recurrence factors and prevention of complications of pediatric differentiated thyroid cancer.
Wang C; Chen X; Wei X; Chen F; Wang Y; Shen Z
Asian J Surg; 2017 Jan; 40(1):55-60. PubMed ID: 27697309
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node biopsy in staging of differentiated thyroid cancer: a critical review.
Wiseman SM; Hicks WL; Chu QD; Rigual NR
Surg Oncol; 2002 Nov; 11(3):137-42. PubMed ID: 12356509
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.
Zhao H; Huang T; Li H
Surgery; 2019 Jul; 166(1):55-60. PubMed ID: 30876667
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of nodal metastases on local recurrence in the management of differentiated thyroid cancer. Retrospective clinical study.
Conzo G; Docimo G; Pasquali D; Mauriello C; Gambardella C; Esposito D; Tartaglia E; Della Pietra C; Napolitano S; Rizzuto A; Santini L
BMC Surg; 2013; 13 Suppl 2(Suppl 2):S3. PubMed ID: 24267409
[TBL] [Abstract][Full Text] [Related]
11. Role of sentinel lymph node biopsy in thyroid cancer.
Roh JL; Koch WM
Expert Rev Anticancer Ther; 2010 Sep; 10(9):1429-37. PubMed ID: 20836678
[TBL] [Abstract][Full Text] [Related]
12. [Distribution of cervical lymph node metastasis in well-differentiated thyroid carcinoma].
Bian X; Xu ZG; Zhang B; Liu WS; Mao CY; Tang PZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2006 Aug; 41(8):599-602. PubMed ID: 17039802
[TBL] [Abstract][Full Text] [Related]
13. Skip metastases in thyroid cancer leaping the central lymph node compartment.
Machens A; Holzhausen HJ; Dralle H
Arch Surg; 2004 Jan; 139(1):43-5. PubMed ID: 14718274
[TBL] [Abstract][Full Text] [Related]
14. Surgical management of cervical lymph nodes in differentiated thyroid cancer.
Fritze D; Doherty GM
Otolaryngol Clin North Am; 2010 Apr; 43(2):285-300, viii. PubMed ID: 20510715
[TBL] [Abstract][Full Text] [Related]
15. Nodal metastases in thyroid cancer: prognostic implications and management.
Wang LY; Ganly I
Future Oncol; 2016 Apr; 12(7):981-94. PubMed ID: 26948758
[TBL] [Abstract][Full Text] [Related]
16. Positive Lymph Node Counts in American Thyroid Association Low-Risk Papillary Thyroid Carcinoma Patients.
Griffin MJ; Baik FM; Brandwein-Weber M; Qazi M; Yue LE; Osorio M; Urken ML
World J Surg; 2020 Jun; 44(6):1892-1897. PubMed ID: 32055968
[TBL] [Abstract][Full Text] [Related]
17. Papillary thyroid cancer: controversies in the management of neck metastasis.
Davidson HC; Park BJ; Johnson JT
Laryngoscope; 2008 Dec; 118(12):2161-5. PubMed ID: 19029855
[TBL] [Abstract][Full Text] [Related]
18. Breach of the thyroid capsule and lymph node capsule in node-positive papillary and medullary thyroid cancer: Different biology.
Machens A; Dralle H
Eur J Surg Oncol; 2015 Jun; 41(6):766-72. PubMed ID: 25468749
[TBL] [Abstract][Full Text] [Related]
19. Differentiated and Medullary Thyroid Cancer: Surgical Management of Cervical Lymph Nodes.
Asimakopoulos P; Nixon IJ; Shaha AR
Clin Oncol (R Coll Radiol); 2017 May; 29(5):283-289. PubMed ID: 28094086
[TBL] [Abstract][Full Text] [Related]
20. Metastases to the regional lymph nodes, lymph node recurrence, and distant metastases in nonadvanced papillary thyroid carcinoma.
Sugino K; Kure Y; Iwasaki H; Ozaki O; Mimura T; Matsumoto A; Ito K
Surg Today; 1995; 25(4):324-8. PubMed ID: 7633123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
